Physician profile
Rajeev L Narayan
NPI 1376727305
$115,567.61
in general payments reported to CMS, 2019-2025
28 companies · $2,877 in 2025
The $2,877 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $60K · 2020: $14K · 2021: $16K · 2022: $7,565 · 2023: $9,052 · 2024: $6,248 · 2025: $2,877.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $9,350 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,675 · Food and Beverage: $2,810 · Travel and Lodging: $1,793 · Consulting Fee: $550.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $9,350.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,675.00 |
| Food and Beverage | $2,809.92 |
| Travel and Lodging | $1,792.87 |
| Consulting Fee | $550.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $33,939.44 | 2019-2025 | Impella |
| Medtronic Vascular, INC. | $25,581.36 | 2019-2020 | |
| Shockwave Medical, INC | $17,569.77 | 2020-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abbott Laboratories | $12,321.61 | 2019-2025 | Mitraclip, Amplatzer Talisman |
| Medtronic, INC. | $12,067.63 | 2021-2024 | Corevalve Evolut R, Avalus, Azure Xt Dr Mri Surescan |
| Boston Scientific Corporation | $6,780.07 | 2019-2025 | Rotapro, Avvigo Guidance System, Watchman |
| Edwards Lifesciences Corporation | $5,714.20 | 2019-2025 | Evoque, Pascal, Sapien 3 Ultra Resilia |
| Novartis Pharmaceuticals Corporation | $395.70 | 2019-2025 | |
| Amgen INC. | $238.98 | 2019-2025 | Repatha |
| Astrazeneca Pharmaceuticals LP | $162.29 | 2019-2021 | |
| Cardiovascular Systems INC. | $133.66 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $130.18 | 2019 | |
| Vifor Pharma, INC. | $106.67 | 2019-2020 | |
| Bard Peripheral Vascular, INC. | $72.40 | 2019-2020 | |
| Teleflex LLC | $50.34 | 2023-2025 | Langston, Manta |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $46.50 | 2025 | Indigo System |
| E.R. Squibb & Sons, L.L.C. | $37.02 | 2019-2023 | Eliquis |
| Inari Medical, INC. | $36.49 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Janssen Pharmaceuticals, INC | $31.62 | 2019 | |
| Impulse Dynamics (USA) INC. | $30.72 | 2023 | Optimizer |
| Kiniksa Pharmaceuticals, LTD. | $23.34 | 2022 | |
| Ekos Corporation | $23.06 | 2019 | |
| Kiniksa Pharmaceuticals International, Plc | $17.94 | 2024 | Arcalyst |
| W. L. Gore & Associates, INC. | $16.73 | 2019 | |
| Chiesi USA, INC. | $15.87 | 2019 | |
| Cardinal Health 200 LLC | $12.14 | 2019 | |
| Pfizer INC. | $11.88 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rajeev Narayan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.